Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Latest results with RWJ-54428/MC-02479 presented at ICAAC

Sep. 27, 1999

Roche's breakthrough flu treatment approved in Switzerland

Sep. 27, 1999

FDA requests additional clinical data for Avanir's docosanol cream

Sep. 24, 1999

Licensing opportunity from ASU: use of spongistatin 1 to treat fungal infections

Sep. 24, 1999

Bayer licenses novel penem prodrug in phase II testing

Sep. 23, 1999

FDA approves Rhone-Poulenc Rorer's Synercid

Sep. 22, 1999

Rifalazil: preclinical and clinical results presented at IUATLD conference; development on hold

Sep. 21, 1999

Potential of RSVIG assessed in immunosuppressed animal model

Sep. 21, 1999

Synercid profiled in JAC; U.K. product launch announced

Sep. 20, 1999

FK-041: antibacterial potency in vitro and in vivo

Sep. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...